Search

everythinglearnresearchcommunity

for

Search:↓

These medications for BPH have known risks and may have new side effects.

Cyproterone acetate and ethinylestradiol effectively reduce hirsutism and acne in women.

A cystic fibrosis patient developed Cushing's syndrome from a drug interaction between itraconazole and budesonide, which improved after stopping the medications.

Block and replace therapy improved symptoms in recurrent cyclic Cushing’s disease.

The new compound is a promising, less toxic alternative to finasteride for treating prostate issues.

Overexpressing SSAT enzyme reduces prostate tumor growth in mice.

Long-term treatment with finasteride or combined therapy worsens sexual function in men with urinary issues.

Loop diuretics may double bone loss in elderly men, finasteride lowers prostate cancer risk but may increase high-grade tumors, abarelix reduces testosterone quickly, and transdermal testosterone offers minimal sexual benefit for women.

Cyproterone acetate is a safe treatment that causes mild feminizing effects in adolescent trans-girls.

Certain hydroxycinnamate derivatives may effectively inhibit enzymes linked to hair loss with low toxicity.

Intramuscular cyproterone acetate effectively treats hirsutism and improves skin conditions in women with hyperandrogenism.

A woman's hair grew back after she stopped taking the Parkinson's disease medication pramipexole.

Epristeride's metabolism in zebrafish helps improve doping detection methods.

Combination drug therapies are more effective for high-risk BPS patients but have more side effects and costs.

Monitoring for adverse effects in clinical treatments is crucial.

Different medications can cause serious side effects in some people.

Venlafaxine may cause paranoid delusions in some patients.

Finasteride and CPA-EE2 equally reduce hirsutism, but affect hormone levels differently.

Bupropion causes more hair loss than other antidepressants, with paroxetine causing the least.

High doses of cyproterone acetate increase the risk of brain tumors in women, but the risk decreases after stopping the medication.

St. John's Wort may reduce the effectiveness of finasteride by increasing its breakdown in the body.

Finasteride is high-risk for cognitive disorders, while Carbidopa/Levodopa, Topiramate, and Clonazepam are moderate-risk.

Plerixafor may help treat pigmentation disorders by promoting skin repigmentation.

Targeting neurosteroids may help prevent drug relapse.